Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-25-016961
Filing Date
2025-06-12
Accepted
2025-06-12 16:33:58
Documents
2
Period of Report
2025-06-10

Document Format Files

Seq Description Document Type Size
1 form3-06122025_080654.html 3  
1 form3-06122025_080654.xml 3 1710
2 ex24-06122025_080600.htm EX-24 12161
  Complete submission text file 0001415889-25-016961.txt   15278
Mailing Address 828 WINTER STREET WALTHAM MA 02451
Business Address 828 WINTER STREET WALTHAM MA 02451 617-833-1027
Xilio Therapeutics, Inc. (Issuer) CIK: 0001840233 (see all company filings)

EIN.: 851623397 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O XILIO THERAPEUTICS, INC. 828 WINTER STREET WALTHAM MA 02451
Business Address
Bello Akintunde Olatokumbo (Reporting) CIK: 0002070709 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40925 | Film No.: 251043349